Clay Siegall Contributions in the Biotechnology Field.

Clay siegall is the co-founder of Seattle Genetics as well as the company’s chief executive officer and the president. Seattle Genetics targets a variety of autoimmune indications and cancer through its clinical and preclinical products. The company is an antibody technologies leader.

Clay siegall has been of great importance to the Seattle Genetics and has helped the company go through a lot of activities like raising start-up capital, where the corporation was able to secure more than $330 million through private and public financing, and representing the company in global conferences. He has also helped the company to join multiple strategic collaborations which include worldwide collaboration with Genentech, which has a total value of more than $860 million, some ADC collaborations, which include MedImmune, Bayer, Curagen, and Progenics, which has helped in generating more than $65 million.

From 1991 to 1997, Dr. Siegall was working with Bristol-Myers Squibb, an institute of pharmaceutical research. In 1988 to 1991, he worked with National Cancer Institute in national institutes of health. Talking of cancer, Dr. Clay has over 20 years of experience in the field making him knowledgeable in various cancer issues. He sat as a trustee and director on the board of governors of Fred Hutchinson Cancer Research Business Alliances as well as on the board of trustees of Washington Biotechnology and Biomedical Association, which is a private biotechnology company.

Since 2014, Dr.Clay Siegall has been a director of Ultragenyx Pharmaceutical Inc. He has also worked with Mirna Therapeutics as a non-director. Dr.siegall was also a biotechnology and a staff fellow at National Institutes of Health and National Cancer Institute. He holds nine patents and 67 scientific papers.

In 1995, due to his efforts in the targeted toxins sector, he was given the Pierce Award. He was also declared an Ernest and young Pacific Northwest entrepreneur of the year as the healthcare category award finalist. He acquired his PhD in Genetics from the University of George Washington, and also obtained his B.S in Zoology from Maryland University